Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2011, Article ID 458427, 9 pages
Review Article

SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS

1Laboratory of Experimental Neurobiology, IRCCS, National Neurological Institute “C. Mondino,” Via Mondino 2, 27100 Pavia, Italy
2Department of Neurological Sciences, University of Pavia, 27100 Pavia, Italy

Received 15 November 2010; Accepted 3 February 2011

Academic Editor: Prabhakara V. Choudary

Copyright © 2011 Pamela Milani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Copper-zinc superoxide dismutase (SOD1) is a detoxifying enzyme localized in the cytosol, nucleus, peroxisomes, and mitochondria. The discovery that mutations in SOD1 gene cause a subset of familial amyotrophic lateral sclerosis (FALS) has attracted great attention, and studies to date have been mainly focused on discovering mutations in the coding region and investigation at protein level. Considering that changes in SOD1 mRNA levels have been associated with sporadic ALS (SALS), a molecular understanding of the processes involved in the regulation of SOD1 gene expression could not only unravel novel regulatory pathways that may govern cellular phenotypes and changes in diseases but also might reveal therapeutic targets and treatments. This review seeks to provide an overview of SOD1 gene structure and of the processes through which SOD1 transcription is controlled. Furthermore, we emphasize the importance to focus future researches on investigating posttranscriptional mechanisms and their relevance to ALS.